Research peptides studied for growth hormone secretagogue activity including GHRH analogs and selective GHRPs. Includes CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, and IGF-1 LR3 — the most studied GH-related research peptides in preclinical literature. All compounds independently tested by Vanguard Laboratory to ≥99% purity minimum. For research use only.
Showing all 6 results
Modified GRF 1-29 No DAC variant. Primary GHRH analog for GH secretagogue research. ≥99% purity — independently verified by Vanguard Laboratory, ISO/IEC 17025:2017 accredited. Batch-specific COA with every order. For research use only — not for human consumption.
GH secretagogue research blend. CJC-1295 10mg + Ipamorelin 10mg = 20mg total. Most studied GHRH + GHRP combination. ≥99% purity — Vanguard verified. Batch-specific COA. For research use only — not for human consumption.
Long R3 variant of Insulin-Like Growth Factor 1. Extended half-life research analog. ≥99% purity — independently verified by Vanguard Laboratory, ISO/IEC 17025:2017 accredited. Batch-specific COA with every order. For research use only — not for human consumption.
Selective GHRP and ghrelin receptor agonist. Most studied selective growth hormone secretagogue. ≥99% purity — independently verified by Vanguard Laboratory, ISO/IEC 17025:2017 accredited. Batch-specific COA with every order. For research use only — not for human consumption.
GHRH (1-29) analog. Endogenous growth hormone releasing factor research peptide. ≥99% purity — independently verified by Vanguard Laboratory, ISO/IEC 17025:2017 accredited. Batch-specific COA with every order. For research use only — not for human consumption.
Modified GHRH analog. FDA-approved API (Egrifta) in research grade form. ≥99% purity — independently verified by Vanguard Laboratory, ISO/IEC 17025:2017 accredited. Batch-specific COA with every order. For research use only — not for human consumption.
No products in the cart.